Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary Intervention: Results From the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial

✍ Scribed by S.C. Beinart; P. Kolm; E. Veledar

• Book ID: 113415586
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 37 KB
• Volume: 14
• Category: Article
• ISSN: 1062-1458
• DOI: 10.1016/j.accreview.2005.11.046